FDA Adverse Event Injury Summary report: N

ANIMAS INSULIN INFUSION PUMP

MDR report key: 2457288 · Received February 16, 2012

Report

Report Number
2531779-2012-01204
Event Type
Injury
Date Received
February 16, 2012
Date of Event
February 10, 2012
Report Date
February 11, 2012
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K042873
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PUMP HAS NOT BEEN RETURNED TO ANIMAS FOR EVALUATION. ANIMAS HAS CONDUCTED A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS PUMP AND CONFIRMED THAT IT WAS OPERATING WITHIN REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE. IF THE DEVICE IS RETURNED, AN EVALUATION SHALL BE COMPLETED AND A SUPPLEMENTAL REPORT WILL BE FILED. NO CONCLUSIONS CAN BE MADE AT THIS TIME.

Additional Manufacturer Narrative · 1

(B)(4). DEVICE EVALUATION: THE PUMP HAS BEEN RETURNED AND EVALUATED BY PRODUCT ANALYSIS ON (B)(4) 2012 WITH THE FOLLOWING FINDINGS: A REVIEW OF THE TOTAL DAILY DOSE HISTORY SHOWED THAT THE DAILY INSULIN DELIVERY TOTALS CORRECTLY REFLECTED THE USER PROGRAMMED BASAL RATES. NO ACTIVITY OUTSIDE OF NORMAL USE WAS OBSERVED IN THE PUMP BLACK BOX OR DOWNLOAD HISTORY. DURING THE LOAD STEP THE PUMP DID NOT DETECT THE FILLED CARTRIDGE. A FORCE SENSOR CALIBRATION TEST SHOWED THAT THE FORCE SENSOR WAS OUT OF CALIBRATION. THE PUMP WAS OPENED AND CONTAMINATION WAS FOUND IN THE FORCE SENSOR ASSEMBLY. FLOW ACCURACY TESTING WAS UNABLE TO BE COMPLETED DUE TO THE PUMP BEING UNABLE TO LOAD A CARTRIDGE. CORRECTION NUMBER: 2531779-03/24/2010-003-R.

Description of Event or Problem · 1

THE PATIENT REPORTED EXPERIENCING A BLOOD GLUCOSE OF 26 MMOL/L WITH INCREASED THIRST, FREQUENT URINATION, AND TIREDNESS. THE PATIENT REPORTED BOLUSED TO CORRECT FOR ELEVATED BLOOD GLUCOSE AND DROPPED TO 2.3 MMOL/L. THE PATIENT REPORTED TREATING WITH ORAL CARBOHYDRATE AND TEMPORARILY DECREASED BASAL RATE AND BLOOD GLUCOSE LEVELS RESOLVED. CUSTOMER SUPPORT ADVISED THE PATIENT TO DISCUSS SITE ROTATION WITH A HEALTH CARE PROVIDER AS THE PATIENT WAS USING ONLY THE ABDOMEN FOR INFUSION SITES. THIS REPORT IS MADE BASED ON THE ALLEGATION THAT THE PATIENT EXPERIENCED HYPERGLYCEMIA WHILE USING INSULIN PUMP THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ANIMAS INSULIN INFUSION PUMP INSULIN INFUSION PUMP LZG ANIMAS CORPORATION ANM 2020 INSULIN INFUSION PUMP

Patients

Seq Age Sex Outcome Treatment
1 30 YR